hit counter

Autistic Doctors Face Avoidable Barriers in Early Medical Training

MHD card showing a dim hospital corridor whose harsh ceiling lights soften into calm teal pools, a clipboard schedule with ticked steps and a stethoscope, illustrating a review of barriers faced by autistic doctors in early medical training.

Autistic doctors run into avoidable barriers as they move from medical school into their first hospital jobs, according to a 2026 UK review that also proposes a 7-part plan to support them.1 Research Highlights 7 recurring barriers: unspoken social rules, communication exams built around neurotypical styles, noisy wards, unpredictable shift schedules, fast verbal handovers, risky …

Read more

Guanfacine Eases Hyperactivity in Autism; Inflammation Theory Untested

MHD card showing a teal prefrontal dendrite with a magnified membrane of closed HCN channels and an amber microglia cell inside a dashed outline, illustrating that guanfacine eased hyperactivity in autistic children while its anti-inflammatory role remains untested.

Guanfacine, a non-stimulant ADHD medication, reduced hyperactivity in autistic children in a placebo-controlled trial. A 2026 review argues it may also steady prefrontal brain signaling and calm the brain’s immune cells, but that immune effect has never been tested with guanfacine itself.1 Research Highlights Hyperactivity fell in the largest autism trial: in 62 autistic children, …

Read more

Prenatal PM2.5 Linked to Autism-Relevant Newborn Amino Acid Metabolism

MHD featured image for prenatal air pollution, newborn metabolomics, and autism risk.

A matched case-control study of 50 children with autism spectrum disorder and 50 controls found that newborn amino acid metabolism overlapped with both later autism diagnosis and prenatal air-pollution exposure.1 The central pathway, aspartate and asparagine metabolism, was associated with autism (p = 0.01), pregnancy PM2.5 (p < 0.001), first-trimester PM2.5 (p < 0.001), and …

Read more

Bumetanide PROMset Study: 83% Improved in 1 Sensory-Related Domain

MHD featured image for bumetanide and sensory-related parent-reported outcomes in neurodevelopmental disorders.

A 2026 medRxiv preprint using parent-cocreated sensory-related outcome measures found that 83% of children and teens improved on at least 1 PROMIS domain during 6 months of bumetanide treatment.1 The result is interesting, but the unmasked single-case design means the strongest claim is about sensitive outcome tracking, not definitive bumetanide efficacy. Research Highlights Most participants …

Read more

Neonatal Brain MRI Shows Gyri Are Connectivity Hubs by 38-44 Weeks

MHD featured image for neonatal MRI, cortical gyri, sulci, and early brain connectivity.

A 2026 developing Human Connectome Project analysis of 438 full-term neonates found that the newborn cortex already had an adult-like folding hierarchy: gyri connected most strongly to other gyri, sulci connected most weakly to other sulci, and structure-function coupling shifted near 41 to 42 weeks postmenstrual age.1 Research Highlights Gyri were already high-connectivity hubs: across …

Read more